Beyond Commerce Inc (BYOC)

[pennystock_es]

Magic mushroom companies are on the Nasdaq now.

MDMA-assisted therapy for PTSD is in advanced trials, and could receive FDA approval as soon as 2023.

Researchers and recently formed companies, many of them backed by venture capital, are tripping over each other to study and patent the use of psychedelics not only for PTSD, depression, anxiety, and substance use disorders, but also for Alzheimer’s, headaches, fibromyalgia, cognitive impairment associated with schizophrenia, traumatic brain injury, and more. This long list might be the result of laudable scientific curiosity – but it could also be an attempt to find the largest possible number of applications for a potentially profitable drug. Researchers are also exploring ways of administering psychedelics through patentable “tamper-resistant” patches like those that were used for fentanyl.

https://www.theguardian.com/commentisfree/2022/jan/03/us-drugs-magic-mushrooms-wall-street